Information  X 
Enter a valid email address

Optibiotix Health PLC Ord 2P (OPTI)

Related News

17-Sep-2020 09:56 AM

OptiBiotix boosted by Brazilian distribution deal

Life sciences company OptiBiotix Health has announced that subsidiary ProBiotix Health has struck a distribution agreement with Ayalla Marketing. The deal will boost distribution in Brazil of ProBiotix's cholesterol reducing probiotic LPLDL as both
20-Jul-2020 09:08 AM

OptiBiotix Health eyes profitability this year as sales climb

Dietary supplements group OptiBiotix Health said it boosted its first-half revenue, putting each of its divisions on track to becoming profitable this year. Invoiced sales for the six months through June were £742k, up from £149k on-year. &
18-May-2020 10:05 AM

OptiBiotix Health sales rise in first quarter

Dietary supplements group OptiBiotix Health said its revenue jumped in the first quarter, putting its operating divisions on track to be profitable in the current year. Total invoiced sales of the company's LPLDL and SlimBiome products as ingredien
17-Jan-2020 07:40 AM

OptiBiotix Health boosts annual sales, mulls Nasdaq listing

Dietary supplements developer OptiBiotix Health said it boosted its annual revenue as the company transitioned to selling products in development. OptiBiotix Health also said it was also considering a listing on the Nasdaq. Revenue for the year through
28-Aug-2019 08:01 AM

OptiBiotix Health books first-half loss as it inks more distribution pacts

Dietry supplement group for weight loss and cholesterol control OptiBiotix Health booked a first-half loss after modest sales were offset by administrative costs. Pre-tax losses for the six months through May amounted to £1.26m, compared to losses
18-Jul-2019 08:49 AM

OptiBiotix Health inks agreement with BioEnergiser for online distribution of its appetite suppressa

Life sciences business OptiBiotix Health said it had signed an agreement with UK sales and marketing company BioEnergiser for the online distribution of its appetite suppressant SlimBiome Medical in the UK. Under the agreement, BioEnergiser has the righ
29-Apr-2019 08:04 AM

OptiBiotix Health swings to loss as expenses weigh

Obesity, high cholesterol and diabetes treatment developer OptiBiotix Health swung to a full-year loss, as spending offset rising sales and it benefited from an asset sale in the previous year. Pre-tax losses for the year through November amounted to &po
13-Feb-2019 07:51 AM

OptiBiotix Health expects revenue boost as it switches from R&D focus

OptiBiotix Health said it had boosted its annual income as it continued to transition from an R&D business to a commercial company generating sales. Revenue for the year through November had jumped to £541k, up from £191k on-year, with the bu
29-Nov-2018 07:18 AM

OptiBiotix Health grants exclusive license deal to Nutrilinea for the supply of SlimBiome Medical in

OptiBiotix Health agreed to grant an exclusive license agreement to Nutrilinea for the production, packaging, and supply of SlimBiome Medical in Europe with the aim of maximizing the financial return for both parties. The agreement secures manufacturing
30-Aug-2018 09:02 AM

OptiBiotix Health swings to loss amid ongoing transition into commercial business

Life sciences business OptiBiotix Health swung to a first half loss Thursday against a tough comparative from last year, which included gains on the sale of assets. For the six months to 31 May 2018, the company reported a loss before tax to £1.19
21-Jun-2018 07:16 AM

OptiBiotix Health reveals license agreement with ALFASIGMA

OptiBiotix Health entered a license agreement with ALFASIGMA to exclusively commercialise food supplements containing OptiBiotix's cholesterol and blood pressure reducing LPLDL strain in Italy. The agreement is a ten year exclusive license agreement
18-Jun-2018 07:22 AM

OptiBiotix Health enters manufacturing and supply deal with John Morley Foods

OptiBiotix Health entered a manufacturing and supply agreement with John Morley Foods. The agreement grants Morleys an exclusive licence to manufacture and supply the SlimBiome weight management technology in muesli packs within the UK, in return for 50%
31-May-2018 07:42 AM

OptiBiotix signs SweetBiotix deal with global dairy company

OptiBiotix Health, a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, has entered into an evaluation agreement with a global dairy company for its SweetBiotix calorie free sweet fibres. The agreement grants a
23-May-2018 09:54 AM

OptiBiotix Health swing to profit after SkinBiotherapeutics IPO gain

Weight management and cholesterol treatment group OptiBiotix Health swung to an annual profit after a gain made from the IPO of SkinBiotherapeutics offset a weaker operating performance. Pre-tax profit amounted to £1.69m, compared to a loss in the
22-May-2018 02:27 PM

OptiBiotix Health seals US distribution deal with Seed Health

OptiBiotix Health said it had signed a non-exclusive distribution agreement with Seed Health to produce and market products containing its cholesterol management ingredient LP-LDL in the US. Confirmation of the deal comes after discussion were fist flagg
05-Apr-2018 08:13 AM

OptiBiotix Health files three patents

OptiBiotix Health, a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, has filed three new patents. These filings protect the production methods and product application areas arising from OptiBiotix
08-Mar-2018 07:36 AM

OptiBiotix Health to launch SlimBiome in Nutri-Bites with US partner Cereal Ingredients

OptiBiotix Health announced the launch of its award winning SlimBiome in Nutri-Bites with its US partner, Cereal Ingredients (CII), at the 2018 Natural Products Expo West & Engredea. The exhibition is the world's largest trade show for organic, natu
13-Sep-2017 07:06 AM

OptiBiotix Health signs MoU with Bened Biomedical

OptiBiotix Health signed a Memorandum of Understanding (MoU) with Bened Biomedical, Taiwan. The MoU sets the framework for a strategic partnership to explore licensing and sales opportunities and the potential of combining relevant assets, over the next
30-Aug-2017 08:06 AM

OptiBiotix loss widens on higher expenses

OptiBiotix Health, a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, made an operating loss of £980,844 in the first half, compared with a loss of £713,831 a year ago. It said this reflected the i
22-Aug-2017 07:05 AM

OptiBiotix seals new deal with Sacco

OptiBiotix Health announced that, further to the European manufacturing and supply agreement with Sacco announced on 8 March 2017, the company entered a new agreement to cover the US and the Rest Of the World (ROW). The agreement grants Sacco an exclusiv
17-Jul-2017 07:10 AM

OptiBiotix Health seals deal with Pharmabiota NZ

OptiBiotix Health agreed to develop and supply three different products containing LPLDL, with minimum initial purchase of 10,000 boxes of each, to Pharmabiota NZ. Pharmabiota, based in New Zealand, was founded by pharmacist Peter Lagan to provide high q
15-Jun-2017 01:21 PM

All resolutions passed at AGM of OptiBiotix

OptiBiotix Health has confirmed that all resolutions were passed by shareholders at today's Annual General Meeting. At 1:21pm: (LON:OPTI) Optibiotix Health Plc share price was +1.5p at 73p Story provided by
25-Aug-2016 07:34 AM

OptiBiotix widens H1 loss, makes progress

OptiBiotix has widened its H1 pretax loss to £0.7m, from a loss of £0.5m. Revenue was just £88,252, from nil. Administrative expenses figured heavily in both periods. "OptiBiotix has made significant progress in the last six months
10-May-2016 12:50 PM

OptiBiotix passes all resolutions at AGM

OptiBiotix Health has announced that, at the Annual General Meeting of the Company held earlier today, all resolutions were duly passed. At 12:50pm: (LON:OPTI) Optibiotix Health Plc share price was +3p at 91.5p Story provided by
09-Jun-2015 07:42 AM

OPTI, VLG in strategic devepment & commercial alliance

OptiBiotix Health has signed a letter of intent to enter a strategic development and commercial alliance with Venture Life. The alliance brings together OptiBiotix's research and development expertise in developing microbiome modulators to improve
Top categories
Company finder

a d v e r t i s e m e n t